ETF F Shan Zheng Iron Ore (03047.HK) rose 3.6%, leading the list of five major gains in the all-day Express.
F Shan Certificate Iron Ore (03047.HK) closed at HK $14.52, up 3.6%, China Tramway U (09845.HK) closed at US $24.02, up 3.4%, and 02845.HK closed at HK $186.4, up 3.3%. XL II Southern Hengke (07226.HK) closed at HK $4.84, up 3.0%. CICC Jinrui China net-U (09186.HK) charges US $9.50, up 2.8%.
"half Daily Express" five major increases ETF F Shan Zheng Iron Ore (03047.HK) rose 3.3%
F Shan Certificate Iron Ore (03047.HK) closed HK $14.48, up 3.3% 02845.HK China Tramway (02845.HK) closed at HK $186.4, up 3.3% X GX China Tramway-U (09845.HK) closed at US $23.98, up 3.2%, while XL II Southern Hengke (07226.HK) closed at HK $4.846, up 3.1%. Samsung China Dragon Network (02812.HK) received HK $16.92, up 2.2%.
"all-day Express" five major increases ETF XI II Southern Hengke (07552.HK) rose 3.1% to the top of the list.
XI II Southern Hengke (07552.HK) closed at HK $8.875, up 3.1%; fi II Southern country Index (07588.HK) closed at HK $5.265, up 3.1% at HK $8.905 for South China A50 (07348.HK), up 2.4% at HK $15.55 for 03047.HK, up 2.2%. The FI second Southern Hang Seng Index (07500.HK) closed at HK $5.13, up 2.2%.
"half Daily Express" five major increases ETF XI II Southern Hengke (07552.HK) rose 4.4% led the way.
XI II Southern Hengke (07552.HK) closed at HK $8.98, up 4.4%. 03047.HK closed at HK $15.8, up 3.9%. Fi II Southern Hengke Index (07588.HK) closed at HK $5.28, up 3.4%. Fi II Southern Heng Index (07500.HK) closed at HK $5.155, up 2.7%. XI South A50 (07348.HK) received HK $8.87, up 2.0%.
Shanghai Fosun Pharmaceutical A shares rose more than 5% H shares rose more than 7% Guo Guangchang: Fubitai is advancing normally
Shanghai Fosun Pharmaceutical's AH shares rose in intraday trading, with Shanghai Fosun Pharmaceutical's A shares up more than 5 per cent in the afternoon and H shares up more than 7 per cent. Guo Guangchang, chairman of Fosun, replied that Fosun mRNA COVID-19 vaccine approval related work is actively promoted in accordance with normal procedures. "the clinical and examination and approval of Fubitai mRNA vaccine in China has been strongly supported and concerned by many departments, including the Joint Prevention and Control of the State Council, the State Drug Administration, the Shanghai municipal party committee and the municipal government, and related matters are being carried out normally in accordance with the procedures."
"all-day Express" five major increases ETF XL II Southern Hengke (07226.HK) rose 14.8% to the top
XL II Southern Hengke (07226.HK) closed at HK $4.244, up 14.8%; Samsung China Dragon Network (02812.HK) closed at HK $15.31, up 9.0%; Samsung China Dragon Network-U (09812.HK) closed at US $1.954, up 8.6%; 03047.HK Iron Ore (03047.HK) closed at HK $15.50, up 7.8%. CICC Jinrui China net-U (09186.HK) received US $8.295, up 7.7%.